We have located links that may give you full text access.
Increased LDL-cholesterol on a low-carbohydrate diet in adults with normal but not high body weight: a meta-analysis.
American Journal of Clinical Nutrition 2024 January 17
BACKGROUND: LDL-cholesterol (LDL-C) change with consumption of a low-carbohydrate diet (LCD) is highly variable. Identifying the source of this heterogeneity could guide clinical decision-making.
OBJECTIVE: To evaluate LDL-C change in randomized controlled trials (RCTs) involving LCDs, with a focus on body mass index (BMI).
DESIGN: Three electronic indexes (Pubmed, EBSCO, Scielo) were searched for studies between 1 January 2003 and 20 December 2022. Two independent reviewers identified RCTs involving adults consuming <130 g/day carbohydrate and reporting BMI and LDL-C change or equivalent data. Two investigators extracted relevant data which were validated by other investigators. Data were analyzed using a random-effects model and contrasted with results of pooled individual participant data (IPD).
RESULTS: Forty-one trials with 1379 participants and a mean intervention duration of 19.4 weeks were included. In a meta-regression accounting for 51.4% of the observed heterogeneity on LCDs, mean baseline BMI had a strong inverse association with LDL-C change (β=-2.5 mg/dL per BMI unit, CI95% = -3.7 to -1.4), whereas saturated fat amount was not significantly associated with LDL-C change. For trials with mean baseline BMI <25 kg/m2 , LDL-C increased by 41 mg/dL, (CI95% = 19.6 to 63.3) on the LCD. By contrast, for trials with mean BMI 25 to <35 kg/m2 , LDL-C did not change; and for trials with mean BMI ≥35 kg/m2 , LDL-C decreased by 7 mg/dL (CI95% = -12.1 to -1.3). Using IPD, the relationship between BMI and LDL-C change was not observed on higher-carbohydrate diets.
CONCLUSIONS: A substantial increase in LDL-C is likely for individuals with low but not high BMI with consumption of a LCD, findings that may help guide individualized nutritional management of cardiovascular risk. As carbohydrate restriction tends to improve other lipid and non-lipid risk factors, the clinical significance of isolated LDL-C elevation in this context warrants investigation.
SYSTEMATIC REVIEW PREREGISTRATION: PROSPERO, CRD42022299278.
OBJECTIVE: To evaluate LDL-C change in randomized controlled trials (RCTs) involving LCDs, with a focus on body mass index (BMI).
DESIGN: Three electronic indexes (Pubmed, EBSCO, Scielo) were searched for studies between 1 January 2003 and 20 December 2022. Two independent reviewers identified RCTs involving adults consuming <130 g/day carbohydrate and reporting BMI and LDL-C change or equivalent data. Two investigators extracted relevant data which were validated by other investigators. Data were analyzed using a random-effects model and contrasted with results of pooled individual participant data (IPD).
RESULTS: Forty-one trials with 1379 participants and a mean intervention duration of 19.4 weeks were included. In a meta-regression accounting for 51.4% of the observed heterogeneity on LCDs, mean baseline BMI had a strong inverse association with LDL-C change (β=-2.5 mg/dL per BMI unit, CI95% = -3.7 to -1.4), whereas saturated fat amount was not significantly associated with LDL-C change. For trials with mean baseline BMI <25 kg/m2 , LDL-C increased by 41 mg/dL, (CI95% = 19.6 to 63.3) on the LCD. By contrast, for trials with mean BMI 25 to <35 kg/m2 , LDL-C did not change; and for trials with mean BMI ≥35 kg/m2 , LDL-C decreased by 7 mg/dL (CI95% = -12.1 to -1.3). Using IPD, the relationship between BMI and LDL-C change was not observed on higher-carbohydrate diets.
CONCLUSIONS: A substantial increase in LDL-C is likely for individuals with low but not high BMI with consumption of a LCD, findings that may help guide individualized nutritional management of cardiovascular risk. As carbohydrate restriction tends to improve other lipid and non-lipid risk factors, the clinical significance of isolated LDL-C elevation in this context warrants investigation.
SYSTEMATIC REVIEW PREREGISTRATION: PROSPERO, CRD42022299278.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app